placebo for maraviroc

DRUG2 trials

Sponsors

ViiV Healthcare, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Conditions

HIV-1HIV-1 Infection

Phase 2

Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen

CompletedNCT01400412

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsHIV-1 Infection

Start: 2012-01-17End: 2014-06-30Updated: 2024-10-15

Phase 3

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1

TerminatedNCT01345630

ViiV HealthcareHIV-1

Start: 2011-09-30End: 2014-01-31Updated: 2016-01-14

Related Papers

Brief Report: Intracellular Cystatin B Levels Are Altered in HIV-Infected Participants With Respect to Neurocognitive Status and Antiretroviral Therapy

JAIDS Journal of Acquired Immune Deficiency Syndromes2022-09-09

Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study

Clinical Infectious Diseases2015-06-0948 citations

Antiretroviral reduction

AIDS2014-01-068 citations